The T4 formulation by UNI-PHARMA was honored with a Bronze medal at the Centennial Brands awards ceremony, held on Friday, October 23, 2020.

T4 (levothyroxine sodium tablets) is a specialized pharmaceutical product designed for the treatment of thyroid disorders. Having received its marketing authorization on July 29, 1981, production began almost immediately.

The product is available in 13 different dosage strengths, allowing for personalized treatment and ensuring that it meets the needs of all patients with thyroid conditions.